2019 Press Releases

Keyword Search
 
2019 | 2018 | 2017 | 2016 | 2015
DateTitle 
01/04/19NantCell Announces New Celgene Investment
Immunotherapy Company Will Present Findings at the JP Morgan Healthcare Conference in San Francisco on January 7thSecond Round Crossover Funding Brings Celgene's Investment to $105M in NantCell Valued at $4 BillionCurrently Enrolling Patients in Advanced Stage Trials in 15 Indications for Registration IntentDeep Pipeline Of 28 Unique Molecules With 14 First in Human Studies in Over 1,000 Patients to DateLos Angeles, CA, January 4, 2019 – NantCell and it's founder Dr. Patrick Soon-Shiong announce... 
Printer Friendly Version